MacLean MR - Search Results

1

Pulmonary hypertension and the serotonin hypothesis: where are we now?

MacLean MR. MacLean MR. Int J Clin Pract Suppl. 2007 Sep;(156):27-31. doi: 10.1111/j.1742-1241.2007.01497.x. Int J Clin Pract Suppl. 2007. PMID: 17663674 Free article. Review.

2

Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension?

MacLean MR. MacLean MR. J Lab Clin Med. 1999 Aug;134(2):105-14. doi: 10.1016/s0022-2143(99)90114-2. J Lab Clin Med. 1999. PMID: 10444023 Review. No abstract available.

3

Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?

MacLean MR. MacLean MR. Trends Pharmacol Sci. 1999 Dec;20(12):490-5. doi: 10.1016/s0165-6147(99)01389-9. Trends Pharmacol Sci. 1999. PMID: 10603491 Review.

4

5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

MacLean MR, Herve P, Eddahibi S, Adnot S. MacLean MR, et al. Br J Pharmacol. 2000 Sep;131(2):161-8. doi: 10.1038/sj.bjp.0703570. Br J Pharmacol. 2000. PMID: 10991906 Free PMC article. Review. No abstract available.

5

Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.

Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR. Keegan A, et al. Among authors: maclean mr. Circ Res. 2001 Dec 7;89(12):1231-9. doi: 10.1161/hh2401.100426. Circ Res. 2001. PMID: 11739290

6

Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension.

MacLean MR, Deuchar GA, Hicks MN, Morecroft I, Shen S, Sheward J, Colston J, Loughlin L, Nilsen M, Dempsie Y, Harmar A. MacLean MR, et al. Circulation. 2004 May 4;109(17):2150-5. doi: 10.1161/01.CIR.0000127375.56172.92. Epub 2004 Apr 12. Circulation. 2004. PMID: 15078799

7

Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.

Morecroft I, Loughlin L, Nilsen M, Colston J, Dempsie Y, Sheward J, Harmar A, MacLean MR. Morecroft I, et al. Among authors: maclean mr. J Pharmacol Exp Ther. 2005 May;313(2):539-48. doi: 10.1124/jpet.104.081182. Epub 2005 Jan 19. J Pharmacol Exp Ther. 2005. PMID: 15659538

8

Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.

Morecroft I, Dempsie Y, Bader M, Walther DJ, Kotnik K, Loughlin L, Nilsen M, MacLean MR. Morecroft I, et al. Among authors: maclean mr. Hypertension. 2007 Jan;49(1):232-6. doi: 10.1161/01.HYP.0000252210.58849.78. Epub 2006 Nov 27. Hypertension. 2007. PMID: 17130306

9

Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.

Dempsie Y, Morecroft I, Welsh DJ, MacRitchie NA, Herold N, Loughlin L, Nilsen M, Peacock AJ, Harmar A, Bader M, MacLean MR. Dempsie Y, et al. Among authors: maclean mr. Circulation. 2008 Jun 3;117(22):2928-37. doi: 10.1161/CIRCULATIONAHA.108.767558. Epub 2008 May 27. Circulation. 2008. PMID: 18506000

10

Pulmonary hypertension: therapeutic targets within the serotonin system.

Dempsie Y, MacLean MR. Dempsie Y, et al. Among authors: maclean mr. Br J Pharmacol. 2008 Oct;155(4):455-62. doi: 10.1038/bjp.2008.241. Epub 2008 Jun 9. Br J Pharmacol. 2008. PMID: 18536742 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters